CoTherix stock up on drug approval
548696
WASHINGTON (CBS.MW) -- Shares of CoTherix shot up more than 20 percent Thursday as the Belmont, Calif.-based firm announced that the Food and Drug Administration approved its inhaled therapy Ventavis to treat pulmonary arterial hypertension.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.
729663
German drugmaker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for the  prevention of bone tumors in breast cancer patients.
539492
Neurocrine updates investors on the status of its top drugs.
278271
Pharmaceutical stocks were trading slightly higher after news Thursday that GlaxoSmithKline Plc was going to settle with New York Attorney General Eliot Spitzer over allegations the company hid safety studies for its anti-depressant Paxil.
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
395304
AtheroGenics Inc.(AGIX.O: Quote, Profile, Research) said on Monday its AGI-1067 experimental drug showed positive interim results during a Phase IIb trial for treating the hardening of the arteries, sending the shares 60
747572
TORONTO - Biomira Inc. shares rocketed up more than 118 per cent on Friday on some positive results for a lung cancer vaccine the company is developing with Germany&#39;s Merck.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
635340
Shares of CoTherix Inc.  rose 2.7 percent  before the bell on Tuesday after Piper Jaffray initiated coverage of the biopharmaceutical company with an "outperform" rating and a &#36;10 price target.
220351
Shares of ViroPharma (VPHM:Nasdaq - news - research) were among the best-performing health and pharmaceutical stocks Monday after Schering-Plough (SGP:NYSE - news - research) said it would pay $10 million to license ViroPharma&#39;s cold drug.
328806
Shares of Protein Design Labs Inc (PDLI.O: Quote, Profile, Research) rose on Thursday after Swiss drugmaker Roche Holding AG (ROG.
557373
Cambridge Antibody Technology Group Plc  has won a UK court case to get a bigger slice of sales of a  potential blockbuster arthritis medicine, sending its shares  more than 25 percent higher on Monday.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
704148
Shares of NeoPharm Inc. jumped 7 percent Thursday morning after the troubled biotechnology company said it regained licenses for two key cancer medications from Pfizer Inc.